Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers. - Wikidata - wikimedia - TriplyDB

Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

http://www.wikidata.org/entity/Q33896203

about

mTOR signaling in tumorigenesis Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells.Reduced glucocorticoid receptor expression predicts bladder tumor recurrence and progression.Targeting serum glucocorticoid-regulated kinase-1 in squamous cell carcinoma of the head and neck: a novel modality of local control Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer Low SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosis.Targeting the glucocorticoid receptor in breast and prostate cancers.Therapeutic potential of serum and glucocorticoid inducible kinase inhibition.Regulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1.Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects Androgen receptor splice variants in the era of enzalutamide and abiraterone.Ras-ling with new therapeutic targets for metastasis.Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth.The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase.Androgen Signaling in Prostate Cancer.Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway.Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1.Molecular and cellular mechanisms of castration resistant prostate cancer.Serum- and glucocorticoid-dependent kinase-1-induced cell migration is dependent on vinculin and regulated by the membrane androgen receptor.SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT.

P2860

Q28252695-273CBEF9-A63E-4FA6-92EB-79D9FCB6E322 Q34104052-C675D16A-0CEE-4C7A-9310-3AE4DB946D4F Q35111955-AAF4DA08-2EA8-449A-9B0B-47E1F28DF086 Q35499408-1C8967CA-4D98-4983-83D0-B5F68B014F6A Q35631971-5AB02A21-2CF7-400C-B529-8AE9D50C0032 Q36631392-C669D3B4-3BD4-40DF-88E7-6F79EE4116F9 Q36729300-448C69E8-A169-4417-AA1B-6A816A76594E Q38090700-77F52FC7-2E57-4C2D-A26F-7D2BFFAF1263 Q38177872-06F0F28D-F57C-4428-BC97-1C4354790ABA Q38212470-7CFC1A48-C320-4CE5-A51D-5AC18385B52B Q38232413-99261837-53C6-4444-ACCE-06B4BDC621C5 Q38805139-9C764B1B-65F5-4FB6-9896-B66FF12495FA Q38827723-20FE2E65-9EAA-4C79-81A3-087F038EDFC1 Q39021890-27C74BA0-2850-4D77-9EB4-233C51C1BAB9 Q39227656-427AB2FD-6B0B-4758-830D-5F039524932C Q41824705-72693218-4E60-4BBE-B99D-0B940923C01C Q45731755-11C10E4F-F8C8-4A89-92D6-677A99E18894 Q47123500-2037ADF6-5A5B-4D95-AB95-A33C7AB1BD69 Q52608488-CF51FDB5-FE14-4E24-8155-79B34CF69DF8 Q54531699-4F305A65-E963-493F-BA69-5565D25E1515 Q55054888-16B8EED2-F0BB-40B5-B301-BB6CEF8BE77A

P2860

Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

http://www.wikidata.org/entity/Q33896203

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

@ast

Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

@en

type

label

Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

@ast

Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

@en

prefLabel

Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

@ast

Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

@en

P1433

Q33896203-DE0B2812-7719-4034-935F-17DA28E64914

P1476

Q33896203-4F7F46AC-0D35-48AE-8D8B-094DB67296B1

P2093

Q33896203-12E5A544-2AFA-43DD-A028-95D5930D8255

Q33896203-363D0889-592A-4042-87FA-17E310262131

Q33896203-420287C4-11DE-4B9E-A2D7-91B2BF75B6E9

Q33896203-4757A549-E46A-4DEA-9F0D-B0981325114A

Q33896203-6CE96942-37C1-4BE6-B620-7D70B69B5849

Q33896203-727230EC-FB1A-403B-A8A9-ADE1E041F318

Q33896203-A2B1A2B1-8D9C-4668-894B-158C56D65FEF

Q33896203-C710CFFE-665A-4051-8D8A-931A8472A8AE

Q33896203-E4DBBF0D-2545-4A44-8B63-D2969999AEFA

P2860

Q33896203-055B8F73-FA38-430F-BBDC-7056C609472A

Q33896203-0F853B44-DE62-4780-941A-FD74501F8AF3

Q33896203-1256F50A-36AD-4D7B-8C62-95765D91DB50

Q33896203-1C92AAD8-D9DA-442E-9DF1-D928170C0526

Q33896203-1F6C8769-E585-4577-91DD-FDA58E964B17

Q33896203-328414B9-FD31-462A-88EA-C727256C44A7

Q33896203-38DAB13C-BAD3-4154-88CB-725D9B800FF5

Q33896203-42A62C8A-EDB2-498C-83AC-A6238799FDEF

Q33896203-50A7423D-9F32-4998-BC6C-10B515F96257

Q33896203-57716CBC-7DCC-4A94-ABB7-1B05C4FBD785

P304

Q33896203-0F7DE96B-C497-453B-B506-50634F2DB6C7

P31

Q33896203-B1CAE93A-4464-4B9B-906C-D4462CA2CC8D

P356

Q33896203-F59FE2DD-1579-4072-BEE9-7D4A86019AAE

P433

Q33896203-AB73BEF0-4259-4198-8639-03088D472214

P478

Q33896203-01FDB3E1-CA87-428F-8D46-55A8B8609408

P50

Q33896203-B7AA7315-E887-4CF9-B9A6-D6B2BB64AE68

P577

Q33896203-EA749033-87A1-4D23-A56F-FCDA4E3A43D1

P698

Q33896203-09A1F576-1A49-491B-A5B5-99F3627EF8E8

P932

Q33896203-450B329B-4928-48C6-B4E1-8AF979288E3E

P356

P1433

P1476

Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.

@en

P2093

Aria Razmaria

http://www.w3.org/2001/XMLSchema#string

Charles B Brendler

http://www.w3.org/2001/XMLSchema#string

Elizabeth Chung

http://www.w3.org/2001/XMLSchema#string

Gregory P Zagaja

http://www.w3.org/2001/XMLSchema#string

Masha Kocherginsky

http://www.w3.org/2001/XMLSchema#string

Russell Z Szmulewitz

http://www.w3.org/2001/XMLSchema#string

Silver Daniel

http://www.w3.org/2001/XMLSchema#string

Suzanne D Conzen

http://www.w3.org/2001/XMLSchema#string

Walter M Stadler

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity

A complex response element in intron 1 of the androgen-regulated 20-kDa protein gene displays cell type-dependent androgen receptor specificity

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.

Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.

Natural history of progression after PSA elevation following radical prostatectomy.

Cell- and gene-specific regulation of primary target genes by the androgen receptor.

P304

157-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.21416

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Hikmat Al-Ahmadie

P577

2011-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21563193

http://www.w3.org/2001/XMLSchema#string

P932

6000822

http://www.w3.org/2001/XMLSchema#string